In cancer cells, EPHB2 may promote EMT (Gao et al., 2014), and in small extracellular vesicles, EPHB2 may promote angiogenesis, inducing ephrin-B reverse signaling, and STAT phosphorylation (Sato et al., 2019). Here, SOAT1 is linked to cancer.